July 28, 2024

Anatomic Pathology Market: Opportunities And challenges by 2030

The global anatomic pathology market size is expected to be worth around US$ 40.66 billion by 2030, according to a new report by Vision Research Reports.

The global anatomic pathology market size was valued at US$ 17.06 billion in 2020 and is anticipated to grow at a CAGR of 11.08% during forecast period 2021 to 2030.

Anatomic Pathology

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38913

Anatomic Pathology Market Growth Factors

 The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies.

Anatomic Pathology Market Report Coverage
Report Scope Details
Market Size US$ 40.66 Billion by 2030
Growth Rate CAGR of 11.08% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product & services, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Danaher Corporation; PHC Holdings Corporation; Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; F. Hoffmann-La Roche AG; Agilent Technologies, Inc.; Cardinal Health; Sakura Finetek USA, Inc.; NeoGenomics Laboratories, Inc.; BioGenex; Bio SB
By Product & Services Analysis

The consumables segment dominated the market in 2020 with a share of over 65.0%. The availability of a wide range of products, coupled with a high usage rate of consumables in research findings, is fueling the segment growth.

A substantial number of reagents and kits, antibodies, and probes are being marketed for anatomic pathology protocols.The ongoing technological advancements and focused efforts by the market participants to offer anatomic pathological instruments with an improved design are anticipated to bolster the growth of the instruments segment.

By Application Analysis

The disease diagnosis segment accounted for the largest share of over 55.0% in 2020. Pathology protocols provide an opportunity for researchers to explore disease etiology and associated outcomes.

The anatomic pathology workflow aids the detection of a tumor at the inflammatory and proliferating stromal cells stage, thus minimizing costs associated with tumor eradication.

The drug discovery and development segment is anticipated to grow at a lucrative pace over the forecast period. Tissue analysis carried out by the pathologists generates a wealth of information for pharmaceutical manufacturers during preclinical trials.

By End-use Analysis

The hospitals’ segment dominated the market with a revenue share of over 45.0% in 2020 owing to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals.

The hospitals segment is also expected to be befitted by an increasing number of initiatives undertaken by the public and private agencies to promote advanced healthcare systems.

A large number of clinical trials through various ongoing projects spurs the growth of the research laboratories segment.

By Regional Analysis

North America accounted for the largest revenue share of over 45.0% in 2020 due to the presence of major players and supportive government initiatives pertaining to training pathological programs.

 Spiraling demand for advanced imaging modalities, an increase in better patient care facilities, and several pathology laboratories franchising their presence fuels the growth of the Asia Pacific market.

Read also @ Endoscopy Devices Market to Reach US$ 72.9 Billion by 2030

Major Key Players Covered in The Anatomic Pathology Market Report include
  • Danaher Corporation
  • PHC Holdings Corporation
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Cardinal Health
  • Sakura Finetek USA, Inc.
  • NeoGenomics Laboratories, Inc.
  • BioGenex
  • Bio SB
Anatomic Pathology Market Segmentation
  • By Product & Services
    • Instruments
      • Microtomes & Cryostat
      • Tissue Processors
      • Automatic Stainers
      • Whole Slide Imaging (WSI) Scanners
      • Other Products
    • Consumables
      • Reagents & Antibodies
      • Probes & Kits
      • Others
    • Services
  • By Application
    • Disease Diagnosis
    • Drug Discovery and Development
    • Others
  • By End-use
    • Hospitals
    • Research Laboratories
    • Diagnostic Laboratories
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
    • Asia Pacific
      • China
      • India
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Anatomic Pathology Market Snapshot

Chapter 4.  Anatomic Pathology Market Variables and Scope

4.1.  Introduction

4.2.  Anatomic Pathology Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Anatomic Pathology Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Anatomic Pathology Market, By Product

7.1.  Anatomic Pathology Market, by Product, 2021-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Consumables

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Anatomic Pathology Market, By Application

8.1.  Anatomic Pathology Market, by Application, 2021-2030

8.1.1.    Disease Diagnosis

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Drug Discovery and Development

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Anatomic Pathology Market, By End User

9.1.  Anatomic Pathology Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Research Laboratories

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Diagnostic Laboratories

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Diagnostic Laboratories

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Anatomic Pathology Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              Danaher Corporation

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              PHC Holdings Corporation

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Quest Diagnostics Incorporated

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Laboratory Corporation of America Holdings

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              F. Hoffmann-La Roche AG

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Agilent Technologies, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Cardinal Health

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Sakura Finetek USA, Inc.

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              NeoGenomics Laboratories, Inc.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           BioGenex

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38913

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *